NutriBand NTRB
NASDAQ NTRB
$7.28 -0.08 (-1.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

NutriBand (NTRB) Return on Sales [ROS] (2018 - 2026)

Updated

NutriBand's Return on Sales [ROS] came in at -203.57% for fiscal Q2 2027 (quarter ended Jul 31, 2026), up 118.26 percentage points from -321.83% a year earlier and up 85.85 percentage points from the prior quarter.

Analysis

NutriBand (NTRB) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jul 31, 2026, NutriBand reported Return on Sales [ROS] of -435.58%, down 32.08 percentage points year-over-year; for FY2026 (ended Jan 31, 2026), it came in at -408.41%, up 72.29 percentage points from FY2025.

  • Return on Sales [ROS] carries a five-year change of -133.33 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Sales [ROS] was -480.70% in FY2025 (-247.07 pp), -233.63% in FY2024 (-18.44 pp), -215.19% in FY2023 (+214.49 pp) and -429.68% in FY2022 (-154.60 pp).
  • The fiscal Q2 2027 figure represents the highest quarterly Return on Sales [ROS] since fiscal Q2 2024.
  • Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of -54.54 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q4 2026 (a gain of 610.57 percentage points), and the weakest in fiscal Q3 2026 (a drop of 900.35 percentage points).
  • Business Quant data shows NTRB's Return on Sales [ROS] at -289.42% (Q1 2027), -254.78% (Q4 2026) and -1121.30% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 NutriBand 88.49 Mn 71.18 Mn 181,874.00 -203.57%
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -203.57%
Apr 30, 2026 -289.42%
Jan 31, 2026 -254.78%
Oct 31, 2025 -1,121.30%
Jul 31, 2025 -321.83%
Apr 30, 2025 -211.78%
Jan 31, 2025 -865.34%
Oct 31, 2024 -220.94%
Jul 31, 2024 -318.35%
Apr 30, 2024 -462.50%
Jan 31, 2024 -249.01%
Oct 31, 2023 -402.84%
Jul 31, 2023 -125.65%
Apr 30, 2023 -213.42%
Jan 31, 2023 -319.13%
Oct 31, 2022 -173.38%
Jul 31, 2022 -226.73%
Apr 30, 2022 -143.51%
Jan 31, 2022 -767.47%
Oct 31, 2021 -543.55%
API Access

NutriBand Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NTRB&period=max&api_key=YOUR_API_KEY